<DOC>
	<DOCNO>NCT01525290</DOCNO>
	<brief_summary>WAKE-UP investigator initiate European multicenter randomize controlled clinical trial MRI base thrombolysis acute stroke patient unknown time symptom onset , e.g . due recognition stroke symptom awaken . Objective WAKE-UP prove efficacy safety MRI-based intravenous thrombolysis Alteplase patient wake stroke symptom patient otherwise unknown symptom onset .</brief_summary>
	<brief_title>Efficacy Safety MRI-based Thrombolysis Wake-up Stroke</brief_title>
	<detailed_description>WAKE-UP clinical trial MRI base thrombolysis acute stroke patient unknown time symptom onset , e.g . due recognition stroke symptom awaken . Intravenous thrombolysis Alteplase available effective safe treatment acute stroke within 4.5 hour symptom onset . However , 20 % acute stroke patient time symptom onset unknown . This large group patient currently exclude treatment Alteplase . The objective research propose WAKE-UP project provide effective treatment option large group acute stroke patient . WAKE-UP design prove efficacy safety MRI-based intravenous thrombolysis Alteplase patient wake stroke symptom patient otherwise unknown symptom onset . Patients enrol base MRI finding indicative acute ischemic stroke le 4.5 hour age .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Clinical Inclusion Criteria Clinical diagnosis acute ischemic stroke unknown symptom onset ( e.g. , stroke symptom recognize awaken ) Last know well ( without neurological symptom ) &gt; 4.5 hour treatment initiation Measurable disable neurological deficit ( define impairment one following : language , motor function , cognition , gaze , vision , neglect ) Age 1880 year Treatment start within 4.5 hour symptom recognition ( e.g. , awaken ) Written informed consent patient proxy Imaging Acute stroke MRI include diffusion weight imaging ( DWI ) fluid attenuate inversion recovery ( FLAIR ) complete MRI show pattern `` DWIFLAIRmismatch '' , i.e . acute ischemic lesion visibly DWI ( `` positive DWI '' ) mark parenchymal hyperintensity visible FLAIR ( `` negative FLAIR '' ) indicative acute ischemic lesion â‰¤4.5 hour age Clinical Exclusion Criteria Planned anticipate treatment endovascular reperfusion strategy ( e.g . intraarterial thrombolysis , mechanical recanalization technique ) Prestroke disability ( inability carry daily activity , require help supervision , i.e . slight disability correspond MRS score &gt; 1 ) Participation investigational study previous 30 day Severe stroke clinical assessment ( e.g . NIHSS &gt; 25 ) Hypersensitivity Alteplase excipients Pregnancy lactating ( formal testing need woman childbearing potential ; childbearing potential assume woman 55 year age ) Significant bleed disorder present within past 6 month Known haemorrhagic diathesis Manifest recent severe dangerous bleed Known history suspect intracranial haemorrhage Suspected subarachnoid haemorrhage ( even CT negative ) condition subarachnoid haemorrhage aneurysm History CNS damage ( e.g . neoplasm , aneurysm , intracranial spinal surgery ) Recent ( within 10 day ) traumatic external heart massage , obstetrical delivery , recent puncture noncompressible bloodvessel Current use anticoagulant ( e.g . Phenprocoumon , Warfarin , new anticoagulant Dabigatran ) current use heparin elevate thromboplastin time ( lowdose subcutaneous heparin allow ) Platelet count &lt; 100.000/mm3 ( &lt; 100G/l ) Blood glucose &lt; 50 &gt; 400 mg/dl ( &lt; 2.8 22.2 mmol/l ) Severe uncontrolled hypertension , i.e . systolic blood pressure &gt; 185 mmHg diastolic blood pressure &gt; 110 mmHg require aggressive medication maintain blood pressure within limit ( routine medical treatment allow low blood pressure limit ) Manifest recent bacterial endocarditis , pericarditis Manifest recent acute pancreatitis Documented ulcerative gastrointestinal disease last 3 month , oesophageal varix , arterial aneurysm , arterial/venous malformation Neoplasm increase bleed risk Manifest severe liver disease include hepatic failure , cirrhosis , portal hypertension active hepatitis Major surgery significant trauma past 3 month Stroke within 30 day Life expectancy 6 month less judgement investigator Any condition associate significantly increase risk severe bleeding mention Any contraindication MRI ( e.g . cardiac pacemaker ) Imaging Poor MRI quality preclude interpretation accord study protocol Any sign intracranial haemorrhage baseline MRI FLAIR show mark parenchymal hyperintensity region correspond acute DWI lesion indicative acute ischemic lesion high likelihood &gt; 4.5 hour old Large DWI lesion volume &gt; 1/3 MCA &gt; 50 % anterior cerebral artery ( ACA ) posterior cerebral artery ( PCA ) territory ( visual inspection ) &gt; 100 ml Any MRI finding indicative high risk symptomatic intracranial haemorrhage relate potential IVtPA treatment judgement investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>wake-up stroke</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>magnetic resonance imaging ( MRI )</keyword>
	<keyword>diffusion weight imaging ( DWI )</keyword>
	<keyword>fluid attenuate inversion recovery ( FLAIR )</keyword>
</DOC>